KOCAA
KRTX

Knights of Columbus Asset Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,241
Closed -$709K – 404
2023
Q4 		$709K Buy
2,241
+1,089
+95% +$212K 0.05% 270
2023
Q3 		$195K Buy
1,152
+62
+6% +$11.7K 0.02% 314
2023
Q2 		$236K Buy
+1,090
New +$234K 0.02% 307

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Knights of Columbus Asset Advisors's KRTX Position: Q1 2024 in Review

Knights of Columbus Asset Advisors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,241 shares — an estimated $709K sold.

Knights of Columbus Asset Advisors first reported a position in KRTX in Q2 2023 and held it in 3 quarters. The position peaked at $709K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Knights of Columbus Asset Advisors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 2,241 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $709K.
  • Knights of Columbus Asset Advisors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Knights of Columbus Asset Advisors's Karuna Therapeutics, Inc. Common Stock position peaked at $709K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Knights of Columbus Asset Advisors's 13F filing for Q1 2024, filed 10 May 2024.